Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies

[41] Borah P(2004)The pathophysiology of mitochondrial cell death Science 305 162-1065

[42] Deka S(2020)Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020 Indian J Med Res 151 2892-1696

[43] Mailavaram RP(2021)Ectonucleotidases in inflammation, immunity, and cancer J Immunol 206 13444-1703

[44] Deb PK(2022)Therapeutic targeting of Hypoxia-A2-adenosinergic pathway in COVID-19 patients Physiology 37 31199-1115

[45] Borsellino G(2001)Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors J Neurosci 21 83-755

[46] Kleinewietfeld M(2021)From purines to purinergic signalling: molecular functions and human diseases Signal Transduct Target Ther 6 11-1198

[47] Di Mitri D(2019)Therapeutic potential of agonists and antagonists of A1, A2a, A2b and A3 adenosine receptors Curr Pharm Des 25 1054-1283

[48] Sternjak A(2020)Targeting metabolism of extracellular nucleotides via Inhibition of ectonucleotidases CD73 and CD39 J Med Chem 63 1689-231

[49] Diamantini A(2000)Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1 J Biol Chem 275 1661-2969

[50] Giometto R(2017)Extracellular nucleosides and nucleotides as immunomodulators Immunol Rev 280 1113-3744

[41] Borah P(2004)The pathophysiology of mitochondrial cell death Science 305 162-1065

[42] Deka S(2020)Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020 Indian J Med Res 151 2892-1696

[43] Mailavaram RP(2021)Ectonucleotidases in inflammation, immunity, and cancer J Immunol 206 13444-1703

[44] Deb PK(2022)Therapeutic targeting of Hypoxia-A2-adenosinergic pathway in COVID-19 patients Physiology 37 31199-1115

[45] Borsellino G(2001)Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors J Neurosci 21 83-755

[46] Kleinewietfeld M(2021)From purines to purinergic signalling: molecular functions and human diseases Signal Transduct Target Ther 6 11-1198

[47] Di Mitri D(2019)Therapeutic potential of agonists and antagonists of A1, A2a, A2b and A3 adenosine receptors Curr Pharm Des 25 1054-1283

[48] Sternjak A(2020)Targeting metabolism of extracellular nucleotides via Inhibition of ectonucleotidases CD73 and CD39 J Med Chem 63 1689-231

[49] Diamantini A(2000)Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1 J Biol Chem 275 1661-2969

[50] Giometto R(2017)Extracellular nucleosides and nucleotides as immunomodulators Immunol Rev 280 1113-3744